SMITHKLINE BEECHAM Rx SALES UP 5% IN FIRST QUARTER; OTHER DRUG MAJORS ALSO REPORT SLOWER SALES THAN EARNINGS GROWTH; MMD BUCKS TREND WITH 21% SALES GAIN